Who
Jeffrey W. Chell
Director
Company insider
Files Form 4 as: Director, Actinium Pharmaceuticals, Inc. (Delaware).
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Jul 2018
- Last trade
- 2 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)Biotechnology | SEC FORM 4 Code A | —61,600 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —92,400 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —92,400 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)Biotechnology | SEC FORM 4 Code A | —61,600 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —2,500 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —2,500 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —8,333 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —8,333 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —18,351 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —72,156 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code D | —70,311 at $0.00 | filing |
| 28 Dec 2023filed 29 Dec 2023 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —70,311 at $0.00 | filing |
| 1 Jul 2022filed 1 Jul 2022 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —72,156 at $0.00 | filing |
| 1 Sep 2021filed 3 Sep 2021 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —18,351 at $0.00 | filing |
| 12 Aug 2020filed 14 Aug 2020 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 12 Jul 2019filed 16 Jul 2019 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | $58K250,000 at $0.23 | filing |
| 13 Jul 2018filed 17 Jul 2018 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | $59K75,000 at $0.78 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.